Is neoadjuvant chemotherapy always justified in clinical T1 pancreatic ductal adenocarcinoma?. (2021) - Kim, H.S.; Nakagawa, K.; Akahori, T.; Nakamura, K.; Takagi, T.; Sho, M.; Park, J.S.; Yoon, D.S.